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Abstract 
Although it is well-established that severe poisoning by organophosphorus (OP) 
compounds strongly affects the cardiorespiratory system, the effects of sub-lethal 
exposure to these compounds on the neural control of cardiovascular function are 
poorly explored. The aim of this study was to evaluate the effects of acute sub-
lethal exposure to chlorpyrifos (CPF), a commonly used OP insecticide, on three 
basic reflex mechanisms involved in blood pressure regulation, the peripheral 
chemoreflex, the baroreflex and the Bezold-Jarisch reflex. Adult male Wistar rats 
were injected intraperitoneally with a single dose of CPF (30 mg/Kg) or saline 
(0.9%). 24 hours after injections, cardiovascular reflexes were tested in awake rats. 
Potassium cyanide (KCN) and phenylbiguanide (PBG) were intravenously injected 
to activate the chemoreflex and the Bezold-Jarisch reflex, respectively. The 
baroreflex was activated by phenylephrine and sodium nitroprusside infusions. 
Blood samples were taken for measurements of butyrylcholinesterase (BChE) 
activity while acetylcholinesterase (AChE) activity was measured in brainstem 
samples. Animals treated with CPF presented signs of intoxication such as ataxia, 
tremor, lacrimation, salivation, tetany, urination and defecation. The hypertensive 
and the bradycardic responses of the chemoreflex as well as the hypotensive and 
bradycardic responses of the Bezold-Jarisch reflex were all attenuated in CPF 
treated animals (P<0.05). Concerning the baroreflex responses, CPF treatment 
reduced the bradycardia plateau, the range and the gain of the reflex (P<0.05). 
Plasma BChE and brainstem AChE were both reduced significantly after CPF 
treatment (P<0.05). Our results showed that acute sub-lethal exposure to CPF 
impairs the cardiovascular responses of homeostatic and defensive cardiovascular 
reflex. These effects are associated with a marked inhibition of plasma BChE and 
brainstem AChE.  
Keywords: Chlorpyrifos; Baroreflex; Bezold-Jarisch reflex; Peripheral 
Chemoreflex; Butyrylcholinesterase; Acetylcholinesterase 
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Introduction 
It is well established that severe poisoning by organophosphorus (OP) compounds 
produce marked pathological changes in the autonomic, somatic and central 
nervous systems (Tafuri & Roberts 1987; Marrs 1993; Clark 2006; King & Aaron 
2015). Chlorpyrifos (CPF), a common and highly used broad spectrum OP 
insecticide, exerts its predominant toxicological effect by inhibition of 
acetylcholinesterase (AChE), the enzyme that breaks down acetylcholine (Risher & 
Navarro 1998; Marty et al. 2012; Reiss et al. 2012). Similar to other OP 
compounds, inhibition of AChE leads to overstimulation of cholinergic nicotinic and 
muscarinic receptors giving rise to a wide range of potentially lethal side effects. In 
particular, interference with cardiorespiratory homeostasis may cause symptoms 
of, for example: hypotension, hypertension, bradycardia, tachycardia, ventricular 
arrhythmias, ECG changes, bronchoconstriction, increased bronchial secretions, 
respiratory paralysis, cyanosis and cardiac arrest (Marrs 1993; King & Aaron 
2015). However, despite these prominent clinical features of OP poisoning, very 
few studies have elucidated the effects on reflex control mechanisms involved in 
regulating the cardiovascular system. 
The maintenance of adequate tissue perfusion is achieved by an integrative action 
of short- and long term control mechanisms. Neural reflexes exert a moment to 
moment control of cardiovascular function to correct and maintain blood flow and 
oxygen supply to tissues (Spyer 1990; Guyenet 2006; Thomas 2011; Salman 
2016). The baroreflex is one of the most important and powerful reflexes for 
regulating arterial pressure; this is performed by mechanoreceptors located within 
the aortic arch and the carotid sinuses, which mediate reflex responses through the 
brainstem and the parasympathetic and sympathetic outflow to the heart and 
vessels. When arterial pressure is increased, the consequent baroreceptor 
discharge promotes inhibition of the sympathetic drive to heart and vessels and 
activation of the parasympathetic outflow to the heart, decreasing vascular 
resistance, heart rate and cardiac output in order to bring pressure levels back to 
normal (Spyer 1990; Guyenet 2006; Thomas 2011; Salman 2016).  
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Despite the marked role played by the arterial baroreflex, cardiopulmonary 
receptors located within the heart, aorta and lungs are also involved in neural reflex 
control of the circulation (Zanchetti and Mancia, 1991). These receptors respond to 
either chemical or mechanical stimuli; activation of the former mediates the Bezold-
Jarisch reflex (Aviado and Guevara Aviado, 2001). This reflex is activated by toxic 
and irritant agents promoting a powerful vagal mediated bradycardia due to 
parasympathetic activation and a hypotensive response due to withdrawl of 
sympathetic vasoconstriction tone and a decrease in cardiac output (Campagna 
and Carter, 2003; Salman, 2016; Sapru, 2002).  
Changes in pO2, pCO2 and pH can also trigger cardiorespiratory reflex responses 
by activation of peripheral and central chemoreceptors (Kara et al., 2003). The 
peripheral chemoreceptors are located in the carotid and aortic bodies and are 
mainly sensitive to hypoxic states (Prabhakar & Peng 2004; Nurse 2010). The 
cardiorespiratory responses are again mediated by an intricate reflex network that 
passes via the brainstem producing a dramatic increase in sympathetic outflow to 
vessels and in vagal discharge to the heart combined with a hyperventilatory 
response in order to restore oxygen levels (Machado, 2001; Barros et al., 2002; 
Sapru, 2002; Spyer & Gourine, 2009).  
Malfuction of the integrative cardiorespiratory function of these reflexes is 
associated with the development and maintenance of pathological states such as 
hypertension, hypotension, heart failure, dyspnoea and apnoea (Zanchetti & 
Mancia, 1991; Vasquez et al. 1997; Guyenet 2006; Simms et al. 2007; Molkov et 
al. 2014; Fernandez et al. 2015). Previous studies from our laboratory showed that 
acute exposure to an OP compound, methamidophos, impaired the cardiovascular 
responses of two neural reflexes, the peripheral chemoreflex and the Bezold-
Jarisch reflex (Maretto et al., 2012). However, the effects of OP exposure on the 
baroreflex regulation remained unexplored.Despite the commom cholinergic 
interference shared by all OP compounds, there is evidence that cardiac, 
enzymatic and central interaction of these agents may vary according to the 
specific compound type (Howard and Pope, 2002; Kwong, 2002; Mirajkar and 
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Pope, 2008; Pope, 1999; Slotkin et al., 2006; Storm et al., 2000). Therefore, we 
decided to investigate the effects of an acute sub-lethal exposure to CPF, another 
OP insecticide, on the baroreflex, chemoreflex and the Bezold-Jarisch reflex. Since 
the main CNS nuclei involved in mediating these reflexes are located within the 
brain stem, we determined the AChE activity in this specific brain region as well as 
the plasma BChE; this allowed us to associate any changes in cardiovascular 
reflex function with the change in cholinergic transmission.  
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Methods 
Animals 
Adult male Wistar rats weighting between 350-400g were used. The animals were 
provided by the animal facilities of the Health Sciences Center of the Federal 
University of Espírito Santo. Rats were housed in groups of 5/cage at a 
temperature (20–24 ± 1ºC) and humidity controlled room with a 12 h light/dark 
cycle (lights on at 6:30 a.m.). Standard chow and tap water were available ad 
libitum. All experiments were approved by the University Committee for the Ethical 
Use of Animals in Scientific Research (CEUA-UFES; approval numbers 013/2013 
and 024/2013). 
Catheterization Procedure and Pressure Recordings 
The rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p., Cristália 
Produtos Químicos Farmacêuticos Ltda, SP-Brazil) and a catheter (PE-10 
connected to PE-20) was inserted into the abdominal aorta, through the femoral 
artery, to allow arterial pressure recordings and blood sampling. Another catheter 
was inserted into the femoral vein for administration of drugs to activate 
cardiovascular reflexes. Both catheters were tunneled subcutaneously and 
exteriorized through the back of the neck. Rats were allowed to recover overnight 
between surgical procedures and arterial pressure recordings. The pressure 
recordings were performed in awake rats using a pressure transducer interfaced to 
a computer recording system (Powerlab, ADInstruments, New Zealand). Pulsatile 
arterial pressure (PAP), mean arterial pressure (MAP) and heart rate (HR) were 
recorded. The MAP and HR were derived from the pulsatile pressure and were 
analyzed off-line using a digital filter of 0.2Hz. 
Chlorpyrifos (CPF) Treatment 
CPF (Commercial formulation, Lorsban 480 BR, 48% w/v, Dow Agrosciences, 
Brazil) was diluted in saline (NaCl, 0.9% w/v, Vetec Química Fina Ltda, RJ-Brazil) 
for intraperitoneal injections (i.p.) Inert ingredients were also present in the 
composition of the commercial formulation and dilution in saline was promptly 
achieved. Control groups received injections of vehicle (saline, i.p.). Either CPF or 
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saline was given in a volume of 1 ml/kg. The dose of CPF (30 mg/kg) was chosen 
for treatment among five other doses tested (25, 30, 35, 40, 50, 60 mg/kg; data not 
shown) as it produced robust cholinergic signs without inducing lethality. For each 
dose tested, 10-15 animals were injected and the number of deaths counted within 
24 hours. The CPF solution was freshly prepared and always used on the same 
day for each rat. 
Acute toxicity 
A pilot trial was conducted with 10 saline and 10 chlorpyrifos treated rats for 
evaluation of acute toxicity signs. Animals were observed for a period of up to three 
hours after treatment for signs of, for example: ataxia, tremors, lacrimation, 
salivation, tetany, urination and defecation. The presence or absence of these 
signs were recorded and the data expressed as percentage of animals that 
presented each specific behavior against the time since administration of saline or 
CPF (30 mg/kg). Acute toxicity signs were also monitored in all animals tested in 
the cardiovascular reflexes 24 hours after 30 mg/kg CFP dosing (N=30/treatment; 
see Experimental Protocol for description). The data from these animals were 
included with that obtained from those in the pilot trial, so a total of 40 
rats/treatment were utilized. 
Blood Samples 
Blood samples were collected from the femoral artery catheter (0.1ml/collection) 
before and 24 hours after CPF treatment. Samples were collected in heparinized 
plastic microtubes and plasma extracted after centrifugation at 1792 G for 10 
minutes at 4°C (SL-5AM - Spinlab Scientific, South Korea). Samples were used to 
measure the butyrylcholinesterase (BChE) activity, a recognized parameter to 
monitor OP exposure (Eddleston et al., 2008, 2002). Plasma samples were 
collected from CPF and vehicle treated rats and stored at -20°C until the day of the 
assay. 
Brainstem Samples 
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Rats were killed by decapitation and the brain removed rapidly and kept on ice. 
The decapitation procedure was conducted without the use of anesthetic agents 
given the evidence that anesthesia may interfere with the AChE activity (Gomez et 
al., 2000; Pastuszko, 1980; Silva et al., 2005; Valadão et al., 2013; van Rijn et al., 
2011). In order to expose the brainstem, the cerebellum was gently removed with 
tweezers through the disconnection of the cerebellar peduncles. After, two cross 
sections were performed, one at the level of the first cervical region and other at 
the end of the pons. The isolated brainstem was homogenized in ice, using a 
Potter-Elverhjem homogenizer (Tecnal, SP-Brazil), over 5 minutes in phosphate 
buffer (pH= 0.8, 0.1M, Dinâmica, SP-Brazil) and Triton X-100 (1% v/v, Neon, SP-
Brazil) in a proportion of 20 mg of tissue for 1 mL of buffer. Thereafter, the 
homogenates were centrifuged at 7800G for 5 minutes at 4°C (Centrifuge 5804R – 
Eppendorf AG. Hamburg, Germany) and stored at -20°C for no longer than 48 
hours until AChE assay was processed (see AChE.activity for description). 
Chemoreflex activation 
Chemoreflex activation was achieved by randomly assigned intravenous injections 
of potassium cyanide (KCN; 10, 20, 40, 80 µg/rat; Impex, SP, Brazil) according to 
Franchini & Krieger (1993). The peak hypertensive and bradycardic response was 
taken after each dose of cyanide.  
Bezold-Jarisch reflex (BJR) activation 
The BJR was activated by randomly assigned intravenous injections of 
phenylbiguanide (PBG, 1.5, 3.0, 6.0, 12 and 24 µg/kg, Sigma-Aldrich Brasil Ltda, 
RJ-Brazil) as described previously (Maretto et al., 2012; Uggere et al., 2000). The 
peak hypotensive and bradycardic response was quantified after each dose. 
Baroreflex activation 
According to the procedure described by Frigero et al. (2000) and Resstel et al. 
(2004), intravenous infusions of phenylephrine (50 µg/ml, Sigma Chemical) or 
sodium nitroprusside (100 µg/ ml, Commercial formulation, Nitrop, Hypofarma, MG-
Brazil) were used to elicit baroreflex bradycardic and tachycardic responses, 
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respectively. The infusion pump (EFF 311, Insight, SP, Brazil) was adjusted for a 
flow of approximately 0.1 ml/min for phenylephrine and 0.2 ml/min for sodium 
nitroprusside infusions. Infusions did not exceed a volume of 0.1 ml over period of 
30s and produced maximal pressor or depressor responses in the range of ± 40 - 
50 mmHg. 
Evaluation of Baroreflex responses 
Corresponding reflex responses in HR were measured at intervals of ±5 mmHg 
over ± 40 - 50 mmHg; these data were used to construct sigmoidal fitting curves 
(Head and McCarty, 1987; Sampaio et al., 1999) or linear regression curves as 
described previously (Resstel et al., 2004). The parameters obtained from the 
sigmoidal curves were: the tachycardia plateau (TP, bpm), corresponding to the 
maximum increase in HR due to the decrease in arterial pressure after 
nitroprusside injections; the bradycardia plateau (BP, bpm), corresponding to the 
maximum decrease in HR due to phenylephrine induced increase in pressure; the 
range of the reflex (bpm), representing the difference between the TP and the BP; 
the arterial pressure in the midpoint of the curve (AP50, mmHg) and the average 
gain of the reflex (G, bpm/mmHg), given by the slope of the curve, which 
represented the sensitivity of the reflex. From the linear regression curves we 
extracted: the gain of the bradycardic and tachycardic curves, represented by the 
slope of the curves as well as the x-intercept of the regression lines. 
Butyrylcholinesterase (BChE) activity 
BChE activity was measured from the plasma samples taken before and after CPF 
(n=20) and saline (n=16) treatment. Five to seven samples were randomly selected 
from saline and CPF treated animals submitted to each reflex testing (see 
Experimental Protocol for description).The measurements were made with a 
commercial kit (K094, Quibasa, MG, Brazil), according to the colorimetric method 
described by Dietz et al. (1973), with modifications. These measurements were 
made in a semi-automated biochemical analyzer (TP Analyzer Plus, Thermoplate, 
China). The BChE activity was expressed in International Units (I.U./mL), where 
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1.0 I.U. of cholinesterase is equivalent to the amount of enzyme that hydrolyzes 
one mmol of substrate/minute/mL of serum at 37 °C. 
Acetylcholinesterase (AChE) activity 
Measurements of AChE were processed from brainstem samples of CPF and 
saline treated rats (n= 4 per treatment). The enzyme activity was determined using 
the original method described by Ellman et al. (1961) and modified by Lassiter et 
al. (2003). A volume of 135 µl of the brainstem homogenate was added to a 
cuvette containing the following reagents: 35 µl of 0.01M dithio-bisnitrobenzoic acid 
(DTNB), 10µl of 75mM acetylthiocholine (ATCh) and 820 µL phosphate buffer, pH 
8.0, to make a final volume of 1 ml. The development of colour was analyzed at 
412 nm, using a spectrophotometer (Evolution 300 – Thermo Fisher Scientific Inc. 
Waltham, Massachusetts, USA). The acetylcholinesterase activity was expressed 
in milimoles of ATCh hydrolyzed per hour per milligram of protein. The protein 
content of brainstem homogenates was quantified by the method of Bradford 
(1976), using bovine serum albumin as standard. 
Experimental Protocol 
First, rats underwent the catheterization procedure (see above). On the next day, 
blood samples were collect and animals were then treated with saline or CPF and 
observed for up to 3 hours to monitor acute cholinergic signs of poisoning. 
Recordings of baseline levels of MAP and HR as well as activation of the three 
neural reflexes were performed 24 hours after either chlorpyrifos or saline 
treatment. To avoid interference of multiple injections for reflex testing, 10 saline 
and 10 chlorpyrifos treated animals were independently tested for each reflex 
(Total = 30 animals/treatment). For all reflexes tested, a minimal interval of 10 
minutes or complete recovery of basal values was observed between each dose 
assigned. Total recording time, including baseline recordings and reflexes testing, 
ranged from an hour to an hour and a half. At the end of reflex testing, a second 
blood sample was collected from each animal and four animals from each group 
were decapitated for brainstem collection. Experimental duration from dosing to 
sacrifice elapsed within 25 to 26 hours. 
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Statistical analyzes 
The data were analyzed using GraphPad Prism software (version 5.0, USA) or 
Statistical Package for the Social Sciences version 20.0 for Windows (SPSS 
Statistics, Chicago, IL, USA). Acute toxicity signs were analyzed by Pearson’s Chi-
Square test. A two-way ANOVA for repeated measures (RM) followed by 
Bonferroni post hoc test was used for analysis of changes in MAP and HR after 
chemoreflex and BJR activation as well as for the statistical analysis of the BChE 
activity. The baroreflex parameters and the AChE activity within the brainstem 
were analyzed by the Student’s t test. The level of significance was set at *P<0.05. 
The data were expressed as mean ± standard error of the mean (SEM). 
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Results 
Acute toxicity 
The percentage of animals that presented acute toxicity signs as well as the 
latency time for their appearance is shown in Table 1. The animals treated with 
CPF presented ataxia (X2= 43.07), tremor (X2= 62.22), lacrimation (X2= 10.141), 
salivation (X2= 72.381), tetany (X2= 11.429) and a high frequency of urination and 
defecation (X2= 40.833). The only signs observed in saline treated animals were 
urination and defecation. The signs with lowest latency time in CPF treated animals 
were urination and defecation (Table 1). No visual signs of toxicosis were present 
24 hours after CPF dosing. 
 
Effects of CPF treatment on baseline values 
No difference in baseline values of MAP (CPF: 117 ± 1.7; Saline: 118 ± 1.7, t=0.507; 
P> 0.05) or HR (CPF: 322 ± 6.7; Saline: 339 ± 5.8, t=1.933; P>0.05) were observed 
between CPF and saline treated animals 24 hours after dosing. 
Chemoreflex responses 
Figure 1 (A) shows a typical tracing of the KCN induced responses in CPF and 
saline treated animals. The hypertensive and bradycardic responses evoked by 
chemoreflex activation were significantly reduced in CPF treated animals.  
The grouped data of the chemoreflex responses is presented in Figure 1 (B). The 
analysis of the changes in MAP induced by the KCN injections in CPF and saline-
treated animals showed an effect for the treatment (F(1,18)= 26.62; p<0.0001), for 
the KCN doses (F(3,18)= 151.7; p<0.0001) and also showed interaction between the 
treatment and the doses (F(3,18)= 10.45, P<0.0001). The post hoc analysis showed 
that the hypertensive response of CPF treated animals induced by chemoreflex 
activation was decreased for the doses of 20µg (P<0.001), 40µg (P<0.05) and 
80µg (P<0.001) when compared with the same doses in saline-treated rats (Figure 
1B, left panel). 
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Concerning the HR changes induced by KCN, the analysis showed a difference for 
the treatment (F(1,18)= 11.40, P= 0.0034) and for the different doses of KCN (F(3,18)= 
150.50, P<0.0001) as well as an interaction between the treatment and the KCN 
doses (F(3,18)= 5.60, P= 0.002). The post hoc analysis showed that the chemoreflex 
bradycardic response in CPF treated animals was decreased at doses of 20µg 
(P<0.001), 40µg (P<0.05) and 80µg (P<0.005) when compared with the same 
doses in saline-treated rats. 
Cardiovascular responses induced by the Bezold-Jarisch reflex (BJR) 
activation 
As with the chemoreflex, the BJR responses were also decreased in the CPF 
treated rats (Figure 2A). The grouped data are presented in Figure 2B. Concerning 
the MAP changes induced by BJR activation, a difference was observed for 
treatment (F(1,18)= 16.47; p<0.0007) and for the doses of PBG (F(4,18)= 103.9; 
p<0.0001) but there was no interaction between the treatment and the PBG doses 
(F(4,18)= 0.73, P<0.57). The post hoc analysis showed an impairment of the 
hypotensive response of BJR in CPF treated animals at the doses of 1.5µg 
(P<0.001) and 3µg (P<0.05) (Figure 2B, left panel).  
Additionally, our HR analysis showed a difference for the treatment (F(1,18)= 18.64, 
P=0.0004), PBG doses (F(4,18)= 289.0, P<0.0001) and an interaction between the 
treatment and the different doses employed to activate the BJR (F(4,18)= 3.29, 
P=0.0155). The post hoc analysis showed that the bradycardic response induced 
by BJR activation was decreased in CPF treated rats at the doses of 1.5µg 
(P<0.001), 3µg (P<0.05), 12µg (P<0.05) and 24µg (P<0.001) (Figure 2B, right 
panel). 
Baroreflex responses 
A typical baroreflex responses of CPF and saline treated animals is shown in 
Figure 3A. The reflex bradycardic response of CPF treated animals was reduced in 
magnitude when compared with saline treated animals.  
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The pooled baroreflex sigmoidal data are presented in figure 3B. There was a 
reduction in the bradycardia plateau (CPF: -34.0 ± 9.13; Saline: -112.3 ± 14.67; t= 
4.527; P<0.01), the range (CPF: 96.6 ± 11.76; Saline: 183.9 ± 25.54; t= -3.105, 
P<0.01) and the gain (CPF: -0.61 ± 0.12; Saline: -2.37 ± 0.42; t=3,978; P<0.01) of 
the baroreflex of CPF treated animals when compared with saline treated rats 
(Figure 3B, left panel). The linear regression curves showed that the gain of 
bradycardic response was significantly reduced in CPF treated animals compared 
to control (CPF: -1.3 ± 0.23; Saline: -2.9 ± 0.43; t=3.277; P<0.01) (Figure 3B, right 
panel). In contrast, both the AP50 (CPF: -12.7 ± 3.37; Saline: -1.8 ± 4.71; t= -1,881; 
P>0.05) and the tachycardia plateau (t= -0,863; P>0.05) were not different 
between groups (Figure 3B, left panel). No differences were observed in the x-
intercept of the bradycardic curve (CPF 30 = 7.35 ± 1.34; Saline = -3.04 ± 5.35; 
t=1.886; P>0.05) or in the gain and x-intercept of the tachycardic curve (Gain: CPF 
= -1.99 ± 0.28; Saline = -2.54 ± 0.41; t=1.098, P>0.05; x-intercept: CPF= -7.10 ± 
2.06; Saline = -4.66 ± 1.37, t=-0.984; P>0.05). 
Butyrylcholinesterase activity 
BChE activity after CPF treatment was different relative to control (F(1,34)= 26.89, 
P= 0.0001), as well as for the time (F(1,34)= 85.20, P= 0.0001) and showed an 
interaction between treatment and time (F(1,34)= 56.77, P= 0.0001). The post hoc 
analysis showed a reduction in the BChE activity of CPF treated animalsin 
comparison with the pre-treatment condition (BChE before= 210.8 ± 15.40; BChE 
after= 46.7 ± 7.85; P<0.0001) (Figure 4). 
Acetylcholinesterase (AChE) activity 
The AChE activity within the brainstem of CPF treated animals was reduced when 
compared with saline treated rats (Saline= 2.1 ± 0.15; CPF= 0.7 ± 0.06 umol/h/mg 
of protein; t= 8.725, P<0.0001) (Figure 5). 
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Discussion:  
In the present report, we showed that acute intoxication with chlorpyrifos (CPF) 
impairs the cardiovascular responses of three distinct neural reflexes tested. We 
showed that a sub-lethal dose of CPF induced notorious signs of acute toxicity 
observed during the clinical evaluation of the animals after poisoning. These 
effects were also accompanied by a marked inhibition of both plasma BuChE 
activity and AChE within the brainstem. 
For the intoxication procedure, we used a commercial formulation of CPF and 
choose the maximum tolerated dose that did not produce lethality. The use of a 
commercial formulation of CPF for animal’s treatment, instead of the pure 
compound, was adopted to provide similar conditions to the clinical setting. 
Although, it could be argued that interference played by other ingredients present 
in the formulation may bring some uncertainty to the data, the acute toxicity signs 
observed in CPF treated rats as well as the inhibition of the AChE and BChE 
activities after CPF dosing seems to support the effects to be mainly attributed to 
the OP compound. The choice of a high, although sub-lethal dose of CPF, was to 
simulate clinical conditions of a massive acute intoxication by OP compounds, 
which usually occurs among farmers, frequently as a result of self-poisoning in 
suicides attempts (Bochner, 2007; Jeyaratnam, 1990; London et al., 2005). The 
effectiveness of simulating this condition could be ascertained by the frequency of 
acute toxicity signs presented in the CPF treated animals. It is usual in the 
experimental trials involving studies with OP’s exposure to evaluate the acute 
toxicity signs exerted by these compounds as an index of the treatment 
effectiveness. These signs of toxicity with CPF are similar to those reported 
previously (Howard et al., 2007; Moser et al., 1998; Nostrandt et al., 1997; Ruiz-
Muñoz et al., 2011). 
The effectiveness of poisoning was also confirmed by the reduction in plasma 
BuChE activity, when compared to the pre-poisoning condition and with control 
animals. The assay of the BuChE cholinesterase activity is a proven sensitive 
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method for monitoring exposure to OP compounds (Do Nascimento et al., 2017; 
Eddleston et al., 2008; Maretto et al., 2012a; Oliveira-Silva et al., 2000; Pohanka, 
2013). Interestingly, the measurement of BuChE has been proposed as a potential 
marker for predicting cardiovascular risk (Sulzgruber et al., 2015; Sun et al., 2016), 
which further reinforces the importance of measuring this enzyme activity in studies 
involving OP exposure and cardiovascular effects. Measurement of the AChE 
activity within the brainstem, where the main nuclei mediating cardiovascular 
reflexes are located (for review Dampney, 2016; Salman, 2016), complemented 
the results obtained for the plasma BuChE. Animals treated with CPF presented a 
marked inhibition of brainstem AChE activity when compared with control animals. 
Nostrandt and colleagues (1997) showed that rats acutely intoxicated with CPF, 
using a similar dose to that of our study, presented a 60% inhibition of the AChE 
activity in samples of the pons/medulla 24 hours after the intoxication procedure; 
such reduced levels are very similar to that observed in the present study. 
Therefore, inhibition of brainstem AChE confirmed the effectiveness of the 
treatment which correlates with the effects observed on cardiovascular reflex 
function. 
The acute exposure to CPF impaired the bradycardic response of all reflexes 
tested. Previous work from our group showed that acute sub-lethal exposure to 
methamidophos, another OP compound, also impaired the bradycardic response 
of the chemoreflex and of the BJR in rats (Maretto et al., 2012). Considering that 
the reflex-induced reduction in HR is mostly dependent on vagal activation (Aviado 
and Guevara Aviado, 2001; Chianca and Machado, 1996; Costa et al., 2014; 
Dampney, 2016; Gourine et al., 2016, Head and McCarty, 1987; Machado, 2001; 
Salman, 2016; Simms et al., 2007; Spyer and Gourine, 2009) these results indicate 
that exposure to CPF impaired the parasympathetic component of these reflex 
responses. Multiple mechanisms could be involved: First, inhibition of AChE, with 
consequent cholinergic overstimulation might be inducing cholinergic receptors 
desensitization, once it is stablished that sustained agonist cholinergic stimulation 
produces desensitization of both nicotinic and muscarinic receptors (Baumgold et 
al., 1989; Giniatullin et al., 2005; Richelson, 1978). It is well known that either acute 
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or repeated exposure to OPs induces resistance to cholinergic agonist induced 
effects (Costa et al., 1982). Second, the effect observed may not be exclusively 
related to inhibition of acetylcholinesterase, as OP compounds can directly bind to 
nicotinic and muscarinic receptors (Huff et al., 2001; Katz et al., 1997; Pope, 1999; 
Silveira et al., 1990; Udarbe Zamora et al., 2008). Particularly, it has been shown 
that the CPF active metabolite, chlorpyrifos oxon (CPO) binds to M2 cardiac 
muscarinic receptor through diethylphosphorylation, which affects agonist binding 
to the receptor (Bomser and Casida, 2001; Howard et al., 2007; Howard and Pope, 
2002). Therefore, the decrease in the bradycardic response of the three reflexes 
tested might be due to direct inactivation of cardiac muscarinic receptors by CPO. 
It cannot be excluded, however, that exposure to CPF might also affect 
sympathetic function. Although in the linear regression curves only the bradycardic 
gain was significantly reduced in CPF treated animals, the sigmoidal fitting analysis 
of the baroreflex function CPF poisoned animals showed a reduction of the 
baroreflex gain as well as of the reflex range. While the baroreflex range is made 
up of approximately 60% contribution from vagus compared with 40% of the 
sympathetic, the gain is slightly more dependent on the sympathetic component 
than the parasympathetic (Head and McCarty, 1987). Accordingly, the changes 
observed in baroreflex function might suggest interference with sympathetic 
function. This interference could involve modulation of sympathetic ganglia, where 
ganglionic neurotransmission is mainly conducted through the cholinergic system 
(Vernino et al., 2008) or involve modulation within the central nervous system. In 
this regard, evidence has been provided showing the role of central cholinergic 
neurons in the regulation of the sympathetic tone (Buccafusco, 1996). Additionally, 
exposure to soman, another OP compound, induced a short lasting pressor 
response mediated by an increase in sympathetic activity due to central muscarinic 
receptors activation (Brezenoff et al., 1984). Therefore, it is possible that the CPF 
exposure either through desensitization or directly binding to cholinergic receptors 
within brainstem nuclei or at the ganglia might be dampening sympathetic function. 
This hypothesis is reinforced by the CPF-induced reduction in the chemoreflex 
hypertensive response, which is dependent on sympathetic activation to vessels 
 18 
 
(Costa et al., 2014; de Burgh Daly, 1985; Guyenet, 2006; Spyer and Gourine, 
2009). In contrast to our data, Maretto and colleagues (2012) found no changes in 
the chemoreflex induced hypertensive response after exposure to methamidophos. 
However, these differences may relate to the effects played by different OP 
compounds on vascular resistance. Experimental results from Guvenc Tuna et al. 
(2011) have shown that exposure to CPF but not to dichlorvos, another OP 
compound, impairs elastic fibers of the aorta. In fact, differential targets other than 
the common inhibition of AChE has been shown to produce differential toxicities 
among different OP compounds (Chaudhuri et al., 1993; Pope, 1999). The 
reduction in the hypotensive response of the BJR of CPF treated animals, may be 
secondary to the reduction in the bradycardic response after CPF poisoning. In 
fact, Chianca and Machado (1996) showed that methylatropine administration to 
rats not only blocked the BJR bradycardic response but also abolished the reflex-
induced hypotension, suggesting that this response is a consequence of the reflex 
induced reduction in HR and cardiac output.  
Contrary to the modulation in the reflex responses, baseline levels of MAP and HR 
were not significantly different between CPF and control animals, although there 
was a tendency for a reduction in basal heart rate of CPF poisoned animals (CPF: 
322 ± 6.7 vs Saline: 339 ± 5.8). Different effects on arterial pressure and heart rate 
have been observed in clinical reports and in experimental studies with OPs. 
Hypotension, hypertension, bradycardia and tachycardia have all been reported in 
patients acutely intoxicated with OP compounds (Anand et al., 2009; Davies et al., 
2008; Saadeh et al., 1997). However, as these effects involve exposure to different 
OP compounds, at different doses, it is hard to compare the clinical data with the 
present results. A great variation in the experimental data, which may be related to 
differences in the OP compound, dose, route of administration, exposure duration, 
species, methods for monitoring parameters and presence/absence of 
anaesthesia. Intravenous administration of paraoxon as well as of soman to 
Sprague-Dawley conscious rats produced an increase in blood pressure that lasted 
up to 8 hours, which was associated with a light bradycardia (Bataillard et al., 
1990). Brezenoff and colleagues (1984) showed that administration of soman to 
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anaesthetized Sprague-Dawley rats produced a hypertensive response that lasted 
for about 90 minutes, with either bradycardia or tachycardia depending on the 
route of administration. On the other hand, intravenous administration of a lethal 
dose of diazinon or fenthion to anaesthetized rats induced bradycardia followed by 
a decline of blood pressure (Kojima et al., 1992). Subcutaneous administration of a 
sub-lethal dose of CPF to Long-Evans rats lead to an elevation in heart rate which 
lasted for approximately 72 hours (Gordon, 1994). Results from the same research 
group employing oral administration of lower doses of CPF to the same species 
induced sustained hypertension that lasted approximately 32 hours and a short 
lasting bradycardia (Gordon and Padnos, 2000). Anthon and Campanã-Salcido 
(2011), also found a hypertensive response, but with an increase in heart rate that 
lasted up to 24 hours in Wistar rats acutely exposed to CPF for three days. 
Additionally, data from Smith and Gordon (2005) comparing CPF exposure in SHR 
and Wistar Kyoto (WKY) rats, showed much more pronounced and long lasting 
hypertensive and tachycardic effects in SHR than in WKY animals. The authors 
discuss that more pronounced effects observed in SHR rats might relate to a major 
role played by the central cholinergic modulation in the hypertensive state. 
Although, it was not the aim of our study to monitor the immediate changes in MAP 
and HR after exposure it seems that if any changes in baseline values happened 
after exposure they occur within the first hours after exposure. Additionally, the 
difference among the species, OP compounds, the comparison with pre-treatment 
condition, the differences in duration, route and dose of exposure might account for 
the differences observed as well as modulation of an array of reflexes with 
opposing actions.  
Many authors have attempted to establish mortality predictors for acute OPs 
poisoning. It is consensus that even among patients receiving intensive care, such 
as ventilatory support, gastric lavage and standard therapy with the antidotes, 
atropine and pralidoxime, mortality is still high for these groups of individuals. The 
mortality rate in intensive care units is around 10-50% even with mechanical 
ventilation (Banday et al., 2015; Munidasa et al., 2004; Tang et al., 2016). 
Munidasa et al (2004) reported that the mortality rate among the patients studied 
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was 50%, even with mechanical ventilation and oxygen supplementation. The 
authors suggested that the primary contributor to the patient’s mortality when 
respiratory failure is controlled by mechanical ventilation, would be an overall 
impairment of myocardial function together with direct cardiac effects of the OPs. 
This is consistent with our finding that two of the reflexes studied (chemo- and 
BJR) are both protective to the heart. Reducing the potency of protective reflexes 
may well increase myocardial vulnerability to OPs. Indeed, cardiac injury is an 
important cause of death in acute OP poisoning (Aghabiklooei et al., 2013; Anand 
et al., 2009). In addition, an impairment of the chemoreflex function may contribute 
to worsening the respiratory state after poisoning. Increase in pulmonary 
secretions after OP poisoning impairs gas exchange in the lungs (King and Aaron, 
2015; Marrs, 1993). In fact, Gaspari and Paydarfar (2012, 2007) reported that 
mechanical ventilation was not capable of preventing the mortality of rats given a 
lethal dose of dichlorvos. According to the authors, even mechanical ventilation 
with normoxic supplementation was inefficient in maintaining the oxygen blood 
saturation, leading the animals to a hypoxic state. Additionally, with the worsening 
of the animal’s respiratory function, no changes in the baseline cardiovascular 
parameters (blood pressure and heart rate) were observed, which strongly 
suggests that the chemoreflex responses are presumably impaired in OP 
poisoning. 
Important clinical implications have been attribute to acute OP poisoning not only 
during the acute event but also in long term. Hung and colleagues (2015) showed 
in a 12 years’ retrospective cohort study involving patients’ victims of acute OPs 
poisoning in Taiwan, that acute OP poisoning is a significant risk factor for 
development of long term cardiovascular diseases such as arrhythmia, coronary 
artery disease (CAD) or congestive heart failure (CHF). The mechanisms involved 
in the long-term effects are not well understood, but the impairment observed in 
our study could add information on that matter once it is well known that 
impairment in these neural reflexes are important factors associated with the 
development or maintenance of pathological states such as hypertension, 
obstructive sleep apnea, coronary heart disease, congestive heart failure and 
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stroke (Fernandez et al., 2015; Guyenet, 2006; Kara et al., 2003; Meyrelles et al., 
1997; Molkov et al., 2014; Persson, 2005; Simms et al., 2007; Vasquez et al., 
1997) However, whether the impairment in the reflexes function observed in the 
present study is long lasting, is a subject for further investigations. 
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Conclusions:  
Our results showed that acute sub-lethal exposure to CPF impairs the 
cardiovascular responses of three regulatory and protective neural reflexes tested. 
These effects are associated with a marked inhibition of the plasma BuChE and of 
the AChE within the brainstem. The results observed may have important short 
and long term clinical implications in OP poisoning, once if death does not happen 
as a consequence of cardiorespiratory complications, survival after poisoning may 
condition the body to be more vulnerable to cardiovascular risk. 
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Figure 1: A. Representative recordings showing changes induced by intravenous injection of KCN 
doses (10, 20, 40 and 80 µg/rat) in pulsatile arterial pressure (PAP), mean arterial pressure (MAP) 
and heart rate (HR) in CPF and saline treated animals. B. Grouped data showing changes () in MAP 
(left) and HR (right) induced by administration of KCN doses (10, 20, 40 and 80 µg/rat) in CPF (n=10) 
and saline (N=10) treated rats *P<0.05 and **P<0.01 indicates statistical difference between saline 
and CPF for each respective dose. Two-way ANOVA for repeated measures, Bonferroni’s post hoc 
test. 
 
Figure 2. A. Representative recording showing changes induced by intravenous injection of 
phenylbiguanide (PBG) doses (1.5; 3; 6; 12 and 24 µg/kg) in pulsatile arterial pressure (PAP), mean 
arterial pressure (MAP) and heart rate (HR) in CPF and saline treated animals. B. Grouped data 
showing changes () in MAP (left) and HR (right) induced by administration of PBG doses (1.5; 3; 6; 
12 and 24 µg/kg) in CPF (n=10) and saline (N=10) treated rats *P<0.05 and **P<0.01 indicates 
statistical difference between saline and CPF for each respective dose. Two-way ANOVA for 
repeated measures, Bonferroni’s post hoc test. 
 
Figure 3: A. Representative recording showing changes induced by intravenous infusion of 
phenylephrine or sodium nitroprusside in pulsatile arterial pressure (PAP), mean arterial pressure 
(MAP) and heart rate (HR) in CPF and saline treated animals. B. Left panel: Sigmoid curves 
correlating changes () in mean arterial pressure (MAP, mmHg) with changes () in heart rate (HR, 
bpm) in animals treated with saline (continuous line, n=10) or chlorpyrifos (CPF 30 mg/kg, dashed 
line, n=10). Right panel Linear regression curves showing the baroreflex sensitivity for the 
bradycardia and tachycardia responses of animals treated with saline (continuous line, n=10) or 
chlorpyrifos (CPF 30 mg/kg, dashed line, n=10). Student’s t test. 
 
Figure 4. Butyrylcholinesterase activity (UI/mL) of rats before and after treatment with saline (n=16) 
or chlorpyrifos (CPF, 30 mg/kg, n=20). **P<0.01 before and after CPF treatment. Two-way ANOVA 
for repeated measures, Bonferroni’s post hoc test. 
 
Figure 5. Acetylcholinesterase (AChE) activity (umol/h/mg of protein) within the brainstem of rats 
treated with saline (n= 4) or chlorpyrifos (CPF, 30 mg/kg, n= 4). t= 8.725, ** P<0.01 saline vs CPF. 
Student’s t test. 
 
Table 1. Manifestation frequency, in percentage, and latency time, in minutes, for the acute toxicity 
signs after treatment with CPF (30 mg/Kg; n=40) or saline (0.9%; n=40).  
 
